Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Einstein, Montefiore receive NINDS grant to establish clinical site for NeuroNEXT

In a development that could pave the way for treatment for rare neurological diseases and clues to more common ones, physician-scientists at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, have secured a grant to establish a clinical site for the Network for Excellence in Neuroscience Clinical Trials.

2 Dec 2011

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Ceregene, Inc. reported today that it has completed enrollment in its Phase 2b trial of CERE-120, a gene therapy product expressing the neurturin (NRTN) gene for the treatment of Parkinson's disease.

1 Dec 2011

Government inspectors to lawmakers: More must be done to stop prescription of powerful psych drugs to nursing home patients

Government inspectors told lawmakers Wednesday that Medicare officials need to do more to stop doctors from prescribing powerful psychiatric drugs to nursing home patients with dementia, an unapproved practice that has flourished despite repeated government warnings.

1 Dec 2011

New marker may provide more accurate diagnosis of Alzheimer's, FTLD

New research finds a marker used to detect plaque in the brain may help doctors make a more accurate diagnosis between two common types of dementia - Alzheimer's disease and frontotemporal lobar degeneration.

1 Dec 2011

Alzheimer's disease affects women more than men

Many women suffer memory loss and/or confusion at some point in their lives, but as many as 5 million Americans suffer from a much more serious disease, Alzheimer's. According to statistics from the National Institute on Aging, Alzheimer's disease is the most common form of dementia in older people. Alzheimer's is a progressive brain disease; it is irreversible and causes a decline in memory and cognitive skills.

1 Dec 2011

Hospice family caregivers require unique care needs

A study led by the University of Kentucky researcher Elaine Wittenberg-Lyles found that hospice family caregivers are "second order patients" themselves and require their own unique care needs.

1 Dec 2011

Removing amyloid beta can restore sense of smell in mouse model of Alzheimer's

One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease, a study led by a Case Western Reserve University School of Medicine researcher finds.

30 Nov 2011

Eating fish and avoiding violent video games could be prescriptions for a healthier brain

Two new studies presented Wednesday at the Radiological Society of North America’s annual conference in Chicago find that eating plenty of fish and not playing violent video games can keep a person’s brain healthy.

30 Nov 2011

Study highlights importance of diagnosing 'overlap syndrome' in sufferers of ALS, FTD

In order to better counsel patients, it is key for clinicians of different disciplines to be aware of, and diagnose, the 'overlap syndrome' between two medical disorders - ALS and FTD - since it significantly affects patient survival. In her new study, Catherine Lomen-Hoerth, from the University of California San Francisco in the US, also highlights that from a research perspective, identifying the syndrome early is an opportunity to study damaged nerve cells and understand more about the early stages of both ALS and FTD.

30 Nov 2011

Direct link between fish consumption, brain structure and Alzheimer's risk

People who eat baked or broiled fish on a weekly basis may be improving their brain health and reducing their risk of developing mild cognitive impairment (MCI) and Alzheimer's disease, according to a study presented today at the annual meeting of the Radiological Society of North America.

30 Nov 2011

Caregivers have stress reactions that put them at greater risk for physical health problems

When a person with mild cognitive impairment is agitated or restless, caregivers can expect to find they are more edgy as well. According to research conducted at Virginia Tech, the more a caregiver's day is disrupted by the unsettled behaviors of their loved one, the more they find themselves unable to meet or balance their own home and family work loads.

29 Nov 2011

DFG approves establishment of new research training groups

To further enhance the promotion of early-career researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has approved the establishment of 16 new Research Training Groups. This decision was made by the DFG's relevant Grants Committee in Bonn.

29 Nov 2011

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD

Resverlogix Corp. today announced that SUSTAIN, a Phase 2b clinical trial comprised of 176 subjects, is fully enrolled.

28 Nov 2011

New protein involved in defense mechanism against cancer

Researchers of the Swedish medical university Karolinska Institutet and the University of Cologne, Germany, have identified a new protein involved in a defense mechanism against cancer.

28 Nov 2011

Neuralstem initiates spinal cord neural stem cell trial in ALS

Neuralstem, Inc. announced that the first patient to receive stem cells in the cervical (upper back) region of the spine was treated on Friday in its ongoing trial to test the safety of its spinal cord neural stem cells in amyotrophic lateral sclerosis.

23 Nov 2011

JIB highlights aluminium's potential role in neurodegenerative diseases

Aluminium's potential role in neurodegenerative diseases such as Alzheimer's disease and cancer, specifically breast cancer, and the potential role for aluminium adjuvants in vaccine-related adverse effects are spotlighted in the latest issue of the Journal of Inorganic Biochemistry (JIB).

23 Nov 2011

State roundup: Calif. retirees to retain health benefits; Emory, MinuteClinic partner in Ga.; Free services in Md.

Health benefits for government retirees may not be eliminated if state and local governments had clearly promised workers those benefits, the California Supreme Court ruled in an Orange County case Monday. The unanimous ruling is expected to make it more difficult for state and local governments to shave costs by cutting health benefits to retirees if elected officials in previous years made it clear that those benefits would last a lifetime.

23 Nov 2011

Biochemists identify structure of hydroxyurea that specifically inhibits proteasome

As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they need the proteasome for their uncontrolled growth. Biochemists at the Technische Universitaet Muenchen (TUM) have now identified the lead structure of a new class of drugs that attacks the proteasome in an unusual way. New medication could be developed on the basis of this previously unknown binding mechanism.

22 Nov 2011

Alzheimer’s disease progression and body weight may be linked: Study

There have been studies that show that people who are overweight in middle age are more likely to develop Alzheimer's disease decades later than people at normal weight. However some studies also show that people in the earliest stages of Alzheimer's disease are more likely to have a lower body mass index (BMI).

22 Nov 2011

PAREXEL implements fMRI technology in early phase CNS drug development

PAREXEL International, a leading global biopharmaceutical services provider, today announced that it has enhanced its central nervous system (CNS) capabilities for clinical development through the implementation of functional magnetic resonance imaging (fMRI) technology in its Early Phase units.

From Parexel 22 Nov 2011

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Einstein, Montefiore receive NINDS grant to establish clinical site for NeuroNEXT

Enrollment complete in Ceregene's CERE-120 Phase 2b trial for Parkinson's

Government inspectors to lawmakers: More must be done to stop prescription of powerful psych drugs to nursing home patients

New marker may provide more accurate diagnosis of Alzheimer's, FTLD

Alzheimer's disease affects women more than men

Hospice family caregivers require unique care needs

Removing amyloid beta can restore sense of smell in mouse model of Alzheimer's

Eating fish and avoiding violent video games could be prescriptions for a healthier brain

Study highlights importance of diagnosing 'overlap syndrome' in sufferers of ALS, FTD

Direct link between fish consumption, brain structure and Alzheimer's risk

Caregivers have stress reactions that put them at greater risk for physical health problems

DFG approves establishment of new research training groups

Enrollment complete in SUSTAIN Phase 2b clinical trial for atherosclerotic CVD

New protein involved in defense mechanism against cancer

Neuralstem initiates spinal cord neural stem cell trial in ALS

JIB highlights aluminium's potential role in neurodegenerative diseases

State roundup: Calif. retirees to retain health benefits; Emory, MinuteClinic partner in Ga.; Free services in Md.

Biochemists identify structure of hydroxyurea that specifically inhibits proteasome

Alzheimer’s disease progression and body weight may be linked: Study

PAREXEL implements fMRI technology in early phase CNS drug development

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Newsletters you may be interested in